vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $183.2M, roughly 1.1× BLACKLINE, INC.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 2.7%, a 5.6% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 8.1%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $26.1M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 7.9%).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
BL vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.2M | $205.4M |
| Net Profit | $4.9M | $17.0M |
| Gross Margin | 75.2% | 62.5% |
| Operating Margin | 3.7% | 29.6% |
| Net Margin | 2.7% | 8.3% |
| Revenue YoY | 8.1% | 12.9% |
| Net Profit YoY | -91.3% | 35.3% |
| EPS (diluted) | $0.07 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.2M | $205.4M | ||
| Q3 25 | $178.3M | $209.4M | ||
| Q2 25 | $172.0M | $188.0M | ||
| Q1 25 | $166.9M | $177.8M | ||
| Q4 24 | $169.5M | $181.9M | ||
| Q3 24 | $165.9M | $159.3M | ||
| Q2 24 | $160.5M | $145.3M | ||
| Q1 24 | $157.5M | $144.9M |
| Q4 25 | $4.9M | $17.0M | ||
| Q3 25 | $5.3M | $31.5M | ||
| Q2 25 | $8.3M | $12.0M | ||
| Q1 25 | $6.1M | $2.4M | ||
| Q4 24 | $56.4M | $12.5M | ||
| Q3 24 | $17.2M | $9.3M | ||
| Q2 24 | $76.7M | $19.6M | ||
| Q1 24 | $10.8M | $27.7M |
| Q4 25 | 75.2% | 62.5% | ||
| Q3 25 | 75.1% | 61.7% | ||
| Q2 25 | 75.2% | 57.7% | ||
| Q1 25 | 75.5% | 54.8% | ||
| Q4 24 | 75.6% | 54.0% | ||
| Q3 24 | 75.2% | 60.8% | ||
| Q2 24 | 74.9% | 62.5% | ||
| Q1 24 | 75.2% | 63.1% |
| Q4 25 | 3.7% | 29.6% | ||
| Q3 25 | 4.3% | 29.7% | ||
| Q2 25 | 4.4% | 18.7% | ||
| Q1 25 | 2.1% | 12.2% | ||
| Q4 24 | 3.7% | 20.9% | ||
| Q3 24 | 5.0% | 21.9% | ||
| Q2 24 | 1.4% | 32.7% | ||
| Q1 24 | 1.1% | 34.1% |
| Q4 25 | 2.7% | 8.3% | ||
| Q3 25 | 3.0% | 15.0% | ||
| Q2 25 | 4.8% | 6.4% | ||
| Q1 25 | 3.6% | 1.4% | ||
| Q4 24 | 33.3% | 6.9% | ||
| Q3 24 | 10.4% | 5.9% | ||
| Q2 24 | 47.8% | 13.5% | ||
| Q1 24 | 6.9% | 19.1% |
| Q4 25 | $0.07 | $0.48 | ||
| Q3 25 | $0.09 | $0.84 | ||
| Q2 25 | $0.13 | $0.34 | ||
| Q1 25 | $0.10 | $0.07 | ||
| Q4 24 | $0.79 | $0.36 | ||
| Q3 24 | $0.27 | $0.27 | ||
| Q2 24 | $0.22 | $0.52 | ||
| Q1 24 | $0.17 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | $386.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $332.3M | $301.7M |
| Total Assets | $1.8B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $390.0M | $386.7M | ||
| Q3 25 | $419.9M | $285.9M | ||
| Q2 25 | $459.1M | $222.2M | ||
| Q1 25 | $479.5M | $197.8M | ||
| Q4 24 | $885.9M | $162.8M | ||
| Q3 24 | $725.3M | $120.0M | ||
| Q2 24 | $616.6M | $271.6M | ||
| Q1 24 | $331.4M | $318.0M |
| Q4 25 | $332.3M | $301.7M | ||
| Q3 25 | $328.3M | $274.8M | ||
| Q2 25 | $414.0M | $232.2M | ||
| Q1 25 | $417.9M | $234.4M | ||
| Q4 24 | $446.7M | $228.8M | ||
| Q3 24 | $367.9M | $234.3M | ||
| Q2 24 | $325.8M | $216.6M | ||
| Q1 24 | $279.8M | $222.2M |
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | $1.7B | $1.6B | ||
| Q2 25 | $1.8B | $1.6B | ||
| Q1 25 | $1.8B | $1.6B | ||
| Q4 24 | $1.8B | $1.7B | ||
| Q3 24 | $1.7B | $1.6B | ||
| Q2 24 | $1.9B | $1.1B | ||
| Q1 24 | $2.1B | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | $123.0M |
| Free Cash FlowOCF − Capex | $26.1M | $122.4M |
| FCF MarginFCF / Revenue | 14.2% | 59.6% |
| Capex IntensityCapex / Revenue | 0.3% | 0.3% |
| Cash ConversionOCF / Net Profit | 5.46× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | $123.0M | ||
| Q3 25 | $63.8M | $78.4M | ||
| Q2 25 | $32.3M | $72.4M | ||
| Q1 25 | $46.7M | $55.4M | ||
| Q4 24 | $43.8M | $84.6M | ||
| Q3 24 | $55.9M | $-9.0M | ||
| Q2 24 | $40.7M | $67.4M | ||
| Q1 24 | $50.4M | $61.9M |
| Q4 25 | $26.1M | $122.4M | ||
| Q3 25 | $63.3M | $78.3M | ||
| Q2 25 | $31.4M | $72.4M | ||
| Q1 25 | $40.8M | $54.6M | ||
| Q4 24 | $43.0M | $84.1M | ||
| Q3 24 | $55.5M | $-9.2M | ||
| Q2 24 | $40.0M | $67.1M | ||
| Q1 24 | $50.1M | $61.4M |
| Q4 25 | 14.2% | 59.6% | ||
| Q3 25 | 35.5% | 37.4% | ||
| Q2 25 | 18.2% | 38.5% | ||
| Q1 25 | 24.4% | 30.7% | ||
| Q4 24 | 25.4% | 46.2% | ||
| Q3 24 | 33.5% | -5.8% | ||
| Q2 24 | 24.9% | 46.2% | ||
| Q1 24 | 31.8% | 42.3% |
| Q4 25 | 0.3% | 0.3% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 3.6% | 0.4% | ||
| Q4 24 | 0.4% | 0.3% | ||
| Q3 24 | 0.2% | 0.2% | ||
| Q2 24 | 0.4% | 0.2% | ||
| Q1 24 | 0.2% | 0.4% |
| Q4 25 | 5.46× | 7.25× | ||
| Q3 25 | 12.07× | 2.49× | ||
| Q2 25 | 3.90× | 6.05× | ||
| Q1 25 | 7.72× | 22.92× | ||
| Q4 24 | 0.78× | 6.75× | ||
| Q3 24 | 3.24× | -0.96× | ||
| Q2 24 | 0.53× | 3.44× | ||
| Q1 24 | 4.66× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
COLL
Segment breakdown not available.
